Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glioblastomas on the move.

Adrian Merlo1, Bernhard Bettler

  • 1Department of Clinical-Biological Sciences, University Hospitals, University of Basel, Switzerland. amerlo@uhbs.ch

Science'S STKE : Signal Transduction Knowledge Environment
|April 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Functional signatures of de novo GABBR1 and GABBR2 variants associated with neurodevelopmental disorders.

NPJ genomic medicine·2026
Same author

The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors.

British journal of pharmacology·2025
Same author

Exploring GABA and Kisspeptin Roles in Reproductive and Metabolic Regulation: Insights from Kiss1-GABAB1KO Female Mice.

Endocrinology·2025
Same author

Normalization of network activity in an epilepsy model with a constitutively active GABBR2 variant.

Brain : a journal of neurology·2025
Same author

Genetic implication of GABA<sub>B</sub> receptors in the etiology of neurological and psychiatric disorders.

Frontiers in pharmacology·2025
Same author

Binding of HCN channels to GABA<sub>B</sub> receptors in dopamine neurons of the VTA limits synaptic inhibition and prevents the development of anxiety.

Neurobiology of disease·2025

The tumor suppressor PTEN normally slows cancer cell movement. Its phosphatase activity, specifically dephosphorylating threonine-383, is crucial for inhibiting glioblastoma cell migration.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • PTEN (Phosphatase and tensin homolog) is a critical tumor suppressor.
  • The precise mechanisms by which PTEN inhibits cancer cell migration remain incompletely understood.
  • Glioblastoma multiforme exhibits aggressive migratory behavior, contributing to its poor prognosis.

Purpose of the Study:

  • To elucidate the role of PTEN's protein phosphatase activity in regulating glioblastoma cell migration.
  • To identify specific PTEN residues and their phosphorylation status involved in controlling cell motility.

Main Methods:

  • Investigated the impact of PTEN phosphatase-dead mutants on glioblastoma cell migration.
  • Utilized phospho-specific antibodies to assess the phosphorylation state of PTEN at threonine-383.

Related Experiment Videos

  • Employed cell migration assays to quantify migratory phenotypes.

    • Main Results:

    • Loss of PTEN protein phosphatase activity significantly accelerates glioblastoma cell migration.
    • Dephosphorylation of PTEN at threonine-383 is essential for PTEN's tumor suppressive function in migration.
    • Threonine-383 phosphorylation status directly correlates with the inhibition of cell motility.

    Conclusions:

    • PTEN's protein phosphatase activity, through dephosphorylation of threonine-383, is a key regulator of glioblastoma cell migration.
    • These findings offer novel therapeutic targets for inhibiting invasive cancers.
    • Targeting PTEN phosphorylation could represent a strategy for treating glioblastomas.